Brief: Heart Test Laboratories Receives Letter From Nasdaq Indicating Co Is Not In Compliance With Nasdaq Listing Rule
23/12/2022 22:20
Dec 23 (Reuters) - Heart Test Laboratories Inc HSCS.O :
* HEART TEST LABORATORIES INC - ON DEC 21, 2022, CO RECEIVED
LETTER FROM NASDAQ INDICATING THAT IT IS NOT IN COMPLIANCE WITH
NASDAQ LISTING RULE
* HEART TEST LABORATORIES INC - LETTER HAS NO IMMEDIATE
IMPACT ON
THE LISTING OF COMPANY’S COMMON STOCK
Source: (https://bit.ly/3BUXrrO)
Further company coverage: HSCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartSciences
See all newsBrief: Heartsciences Files Definitive Proxy Statement For Proposed Business Combination With Fortitude Mining
Brief: Fortitude Provides Second Quarter 2026 Financial And Operating Highlights
Brief: Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration
Brief: Heartsciences - Files Preliminary Proxy For Business Combination With Fortitude Mining Holdings
Brief: Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights™